Take a Deep Dive Into the AI Revolution
4.4.2022 17:03:00 EEST | Business Wire | Press release
The World AI Cannes Festival (WAICF) is the first global event dedicated exclusively to AI, to tech leaders who innovate in the field and to the economic, human and societal issues which will impact our lives in the very near future. While the first two days will be dedicated to professionals, on the last day of the event, the Palais des Festivals et des Congrès in Cannes will open its doors to the public.
A discovery day for the general public
On Saturday, April 16, WAICF will become a hub of discovery, learning and reflection on AI. This day will give visitors a chance to discover five thematic zones. Each zone will feature a special area for demonstrations and immersive experiences.
WAICF presents AI in the sectors of well-being, beauty, health and luxury. Visit the stands of tomorrow’s key players and enjoy unique experiences in the demonstration areas and Take advantage of the relaxation area to unwind and enjoy the innovative new experiences on offer in this sector.
An exhilarating experience awaits in 140m² of space dedicated to demonstrating AI advances in the field of sport. Test out different sports putting Artificial Intelligence to use, meet industry players and discover AI solutions on offer.
For the first edition of WAICF, the entire first floor of the Palais des Festivals is transformed into an exhibition space focusing on the intersection of Artificial Intelligence and Art. Independent contemporary art curator, Marnie Benney, brings together artists in an inspiring program that includes.
Farming, agriculture, energy, mobility, meet the AI experts working for the good of the environment and discover their innovative solutions.
Experts, speakers and recruiters will be present to welcome the general public in a 135m² space dedicated to Human Resources and present the latest innovations of Artificial Intelligence in this field.
Discover all the experiences on the WAICF website.
Accreditation
In order to request for your accreditation for the WAICF, from 14 to 16 April at Cannes, please write an email to : waicf@agence-profile.com
About the WAICF
The World AI Cannes Festival was born out of the desire to bring together businesses and individuals in Artificial Intelligence. Through a rich and diverse line up, attendees are invited to discover and understand the many ways in which artificial intelligence impacts our daily lives. The World AI Cannes Festival also presents a unique opportunity for businesses to be exposed to innovative ideas, novel information, and new findings. Businesses will be called to showcase their knowledge and experiences as well as to network with leading industry players and decision makers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220404005559/en/
Contact information
Press contact World AI Cannes Festival 2022:
Agence Profile
+33 01 56 26 72 00
Jennifer Loison – +33 6 10 22 52 37 – waicf@agence-profile.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Xylem Announces Segment Leadership Appointments30.6.2026 14:30:00 EEST | Press release
Xylem Inc. (NYSE: XYL), a leading global water solutions company, today announced two executive leadership appointments, effective July 1, both reporting to President and Chief Executive Officer Matthew Pine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630087773/en/ Meredith Emmerich has been appointed EVP and President, Measurement and Control Solutions at Xylem. Meredith Emmerich has been appointed EVP and President, Measurement and Control Solutions. Most recently, she served as EVP and President, Applied Water at Xylem. Emmerich joined Xylem in 2024 from Carrier Global Corporation (NYSE: CARR), where she was Vice President of Global Enterprise Solutions and held several senior leadership roles, including leading the Americas Commercial HVAC business and the Global Residential, Light Commercial, and VRF HVAC portfolio. Emmerich succeeds Mike McGann, who will serve as senior advisor to ensure a smooth and orderly tra
Strike Europe Secures Full MiCA Authorization, Unlocking Bitcoin Services Across All 27 EU Member States30.6.2026 14:29:00 EEST | Press release
Strike, a leading Bitcoin financial services company, today announced that its European entity, Zap (Strike) Europe Limited, has been authorized as a crypto-asset service provider by the Malta Financial Services Authority (MFSA) under the EU's Markets in Crypto-Assets Regulation (MiCA) and the Malta Markets in Crypto Assets Act (Cap. 647, laws of Malta) to provide crypto-asset services. The license enables millions of Europeans across all 27 EU member states to access Strike's suite of Bitcoin financial services under a single regulatory framework, replacing the patchwork of national regimes that previously governed the market. Strike has served eligible European customers since April 2024. The MFSA authorization makes that presence permanent and EU-wide, and positions the company among a small group of firms to complete the MiCA process to date. "Europe deserves a Bitcoin-only company focused on doing one thing well, not a multi-asset platform where Bitcoin is an afterthought," said J
OpZira, Inc. Welcomes Scott Thielman, PhD, as Vice President of Product Development30.6.2026 14:17:00 EEST | Press release
OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced that Scott Thielman, PhD, PE, has joined the company as Vice President of Product Development, effective May 1, 2026. Dr. Thielman brings a unique connection to OpZira’s origins. As Chief Technology Officer of Product Creation Studio, he directed the product development of LumiThera’s Valeda® Light Delivery System - the breakthrough photobiomodulation therapy for dry age-related macular degeneration whose acquisition by Alcon led to the creation of OpZira. His involvement with Valeda gives him firsthand knowledge of the science, clinical vision, and engineering decisions that shaped the technology platform from which OpZira was born. For more than 25 years, Dr. Thielman has directed the development of dozens of FDA-cleared medical devices across ophthalmology, neurostimulation, dermatology, urology, and surgical instrumentation, with partners including Olympus
L&T Technology Services Launches Ainfonix ™ 4.0 to Unlock Engineering Intelligence Across Process Industries30.6.2026 13:45:00 EEST | Press release
L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in Engineering Intelligence Solutions & ER&D Consulting Services, today announced the launch of Ainfonix™ 4.0, a next-generation Engineering Intelligence platform for process industries. Unveiled at EI Live, LTTS’ flagship event that brings together analysts, industry leaders and engineering experts, Ainfonix™ 4.0 marks an important step in the company’s Enterprise AI and Engineering Intelligence strategy. As industrial enterprises accelerate AI adoption, decades of engineering knowledge remain trapped in fragmented drawings, specifications and technical records across disparate systems. Without trusted and accessible engineering data, organizations struggle to realize the full value of AI, automation and digital transformation initiatives. Ainfonix™ 4.0, developed in LTTS’ Sustainability segment, addresses this challenge by transforming engineering artifacts and multi-modal data into structured, asset-linked information
Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients30.6.2026 13:03:00 EEST | Press release
Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick's strength in commercial strategy, medical, creative, digital, analytics, and experience design, they can deliver an unparalleled scientific-to-commercial experience. “We are beyond proud to join forces with Chris, Richard, and the entire team at Oxford PharmaGenesis as we focus on helping life sciences clients think holistically about how evidence, medical strategy, access considerations, and stakeholder engagement connect across the lifecycle with a scientific-to-commercial offer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom